CCEL Historical PE Ratio Notes

— Cryo-Cell International (ticker: CCEL) is a leading private cord blood bank, specializing in the collection, processing, & storage of umbilical cord blood & cord tissue. Founded in 1989, the company provides families with the opportunity to preserve their newborns’ stem cells for potential future medical use, such as for blood disorders, immune system conditions, & regenerative therapies. The demand for Cryo-Cell’s services is influenced by trends in childbirth rates, advances in stem cell research, & broader healthcare awareness. When reviewing historical P/E (price-to-earnings) ratios for CCEL, it’s important to recognize that as a niche healthcare provider, its earnings can be affected by fluctuating customer enrollment, regulatory changes, & substantial investments in research or network partnerships. During periods of strong financial performance or robust industry sentiment, CCEL’s P/E ratio may trend higher, reflecting market optimism. Conversely, operational challenges or uncertainty about the adoption of stem cell therapies can compress earnings & lower the P/E. Thus, shifts in profitability, growth prospects, & sector dynamics will be key factors impacting the historical valuation ratios you observe in CCEL’s financial history.

On this page we presented the Cryo-Cell International Historical PE Ratio information for Cryo-Cell International' stock. The average CCEL historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 22.5. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average CCEL historical PE based on this TTM earnings result method is 31.3. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this CCEL historical PE result, against the recent PE: when this page was posted on 4/13/2026, the most recent closing price for CCEL had been 3.60, and the most recent quarterly earnings result, annualized, was 0.36. Meanwhile, the most recent TTM earnings summed to 0.03. From these numbers, we calculate the recent CCEL PE on 4/13/2026 based on annualized quarterly EPS was 10.0. Based on CCEL's history, that recent PE is low relative to the historical average, with the recent PE 55.6% lower than the historical average PE across our data set for Cryo-Cell International. Looking at the recent CCEL PE on 4/13/2026 based on TTM EPS, we calculate the ratio at 120.0. Based on CCEL's history, that recent PE is elevated relative to the historical average, with the recent PE 283.4% higher than the historical average PE across our Cryo-Cell International data set with TTM EPS used in the calculation at each period.

Another interesting CCEL historical PE Ratio calculation we look at is to take the median earnings per share of the last four quarters for CCEL, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for CCEL, we start with the past four EPS numbers and we first sort them from lowest to highest: -0.13, 0.03, 0.04, and 0.09. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 0.03 and 0.04 — which gives us the median of 0.04. Basically the way to think about this 0.04 number is this: for the trailing four earnings reports, 0.04 marks the "middle ground" number where CCEL has reported a value higher than 0.04 half the time, and has reported a value lower than 0.04 half the time. Annualizing that median value then gets us to 0.16/share, which we use as the denominator in our next PE calculation. With 3.60 as the numerator (as of 4/13/2026), the calculation is then 3.60 / 0.16 = 22.5 as the CCEL PE ratio as of 4/13/2026, based on that annualized median value we calculated.

For self directed investors doing their due diligence on CCEL or any other given stock, valuation analysis for CCEL can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Cryo-Cell International PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for CCEL. Thanks for visiting, and the next time you need to research CCEL Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.